Skip to content

About Us
Our Focus
Pipeline
Partners
Patients
- Overview
- Kid’s Corner
Investors

About Us
Our Focus
Pipeline
Partners
Patients
- Overview
- Kid’s Corner
Investors

About Us
Our Focus
Pipeline
Partners
Patients
- Overview
- Kid’s Corner
Investors

About Us
Our Focus
Pipeline
Partners
Patients
- Overview
- Kid’s Corner
Investors

News

Choose Year
Search Press Releases

Found 176 Results

April 21, 2020

Important COVID-19 Safety Measures for Sernova s 2020 Annual Meeting of Shareholders

March 24, 2020

Sernova Provides Corporate Update and Outlook for 2020

February 17, 2020

Sernova to Present Corporate Update at Noble Capital Markets Investor Conference

February 13, 2020

Sernova Achieves Positive Efficacy Endpoint in Phase I/II Clinical Trial for Type 1 Diabetes

February 10, 2020

Sernova Announces Positive DSMB Review and Recommendation for Continuation of Phase I/II Diabetes Clinical Trial of Cell Pouch

October 24, 2019

Sernova Announces Biotech Veteran as New Chief Financial Officer

October 16, 2019

Sernova Confirms Enduring Levels of Fasting C-Peptide in Bloodstream of First Patient in its Phase I/II Clinical Trial for Type-1 Diabetes

September 17, 2019

Sernova Renews Frontier Flex for Canadian Investor Relations and Marketing

September 10, 2019

Sernova Completes Oversubscribed Private Placement of $4,684,564

September 3, 2019

Sernova Announces Second Closing of Private Placement

«...10...13 141516 17...»

IR Contact

David Burke
Vice President, Investor Relations
917.751.5713
david.burke@sernova.com

Email Alerts Sign-Up

Email

I accept the Privacy Policy

Unsubscribe

Loading...

700 Collip Circle
Suite 114,
London, ON, Canada N6G 4X8
info@sernova.com

Company

About Us
Leadership
Board of Directors
Careers
Contact

Science

Our Focus
Type 1 diabetes
Pipeline
Library

Investors

Overview
News
Events
Financial Reports
Stock Information
Corporate Governance

Privacy Policy
Legal Notice

© 2025 Sernova Biotherapeutics. All rights reserved.

Scroll to Top